In vitro association of the phosphatidylinositol 3‐kinase regulatory subunit (p85) with the human insulin receptor
- 1 November 1995
- journal article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 46 (5) , 346-353
- https://doi.org/10.1111/j.1399-3011.1995.tb01067.x
Abstract
The insulin receptor, as a consequence of ligand binding, undergoes autophosphorylation of critical tyrosyl residues within the cytoplasmic portion of its beta-subunit. The 85 kDa regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85), an SH2 domain protein, has been implicated as a regulatory molecule in the insulin signal transduction pathway. For the present study, glutathione S-transferase (GST) fusion proteins of p85 SH2 domains were used to determine if such motifs associate directly with the autophosphorylated human insulin receptor. The p85 N + C (amino plus carboxyl) SH2 domains were demonstrated to associate with the autophosphorylated beta-subunit, while neither the GTPase activator protein (GAP) N SH2 domain nor the phospholipase C-gamma 1 (PLC gamma 1) N + C SH2 domains exhibited measurable affinity for the activated receptor. The p85 N SH2 domain demonstrated weak association with the insulin receptor, while the p85 C SH2 domain alone formed no detectable complexes with the insulin receptor. The association of p85 N + C SH2 domains with the autophosphorylated receptor was competed efficiently by a 15-residue tyrosine-phosphorylated peptide corresponding to the carboxyl-terminal region of the insulin receptor, but not by phosphopeptides of similar length derived from the juxtamembrane or regulatory regions. The insulin receptor C domain phosphopeptide inhibited the p85 N + C SH2 domain-insulin receptor complex with an IC0.5 of 2.3 +/- 0.35 microM, whereas a 10-residue phosphopeptide derived from the insulin receptor substrate 1 (IRS-1) competed with an IC0.5 of 0.54 +/- 0.10 microM. These results demonstrate that, in vitro, there is an association between the p85 regulatory protein and the carboxyl-terminal region of the activated insulin receptor that requires the presence of both the N and C SH2 domains. Furthermore, formation of the p85/insulin receptor complex may lead to signaling pathways independent of IRS-1.Keywords
This publication has 43 references indexed in Scilit:
- Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain bindingBiochemistry, 1993
- Phosphatidylinositol-3-kinase is a non-tyrosine phosphorylated member of the insulin receptor signalling complexBiochemical and Biophysical Research Communications, 1992
- SH2 and SH3 domains: From structure to functionCell, 1992
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinasesCell, 1991
- cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptorCell, 1991
- Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor ReceptorsScience, 1990
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- Human insulin receptor and its relationship to the tyrosine kinase family of oncogenesNature, 1985